Abstract: The present invention relates to a process for the preparation of Chlorpromazine hydrochloride of structural formula I with a high degree of purity, specifically with a low content of genotoxic impurities.
| # | Name | Date |
|---|---|---|
| 1 | 201621010157-FORM 2-20-03-2017.pdf | 2017-03-20 |
| 2 | 201621010157-FORM 2(TITLE PAGE)-20-03-2017.pdf | 2017-03-20 |
| 3 | 201621010157-DESCRIPTION(COMPLETE)-20-03-2017.pdf | 2017-03-20 |
| 4 | 201621010157-CORRESPONDENCE-20-03-2017.pdf | 2017-03-20 |
| 5 | 201621010157-CLAIMS-20-03-2017.pdf | 2017-03-20 |
| 6 | 201621010157-ABSTRACT-20-03-2017.pdf | 2017-03-20 |
| 7 | 201621010157-FORM 5-27-03-2017.pdf | 2017-03-27 |
| 8 | 201621010157-CORRESPONDENCE-27-03-2017.pdf | 2017-03-27 |
| 9 | ABSTRACT1.jpg | 2018-08-11 |
| 10 | 201621010157-Other Patent Document-230316.pdf | 2018-08-11 |
| 11 | 201621010157-Form 3-230316.pdf | 2018-08-11 |
| 12 | 201621010157-Form 2(Title Page)-230316.pdf | 2018-08-11 |
| 13 | 201621010157-Form 1-230316.pdf | 2018-08-11 |
| 14 | 201621010157-Form 18-200320.pdf | 2020-06-11 |
| 15 | 201621010157-Correspondence-200320.pdf | 2020-06-11 |
| 16 | 201621010157-US(14)-HearingNotice-(HearingDate-21-10-2021).pdf | 2021-10-18 |
| 17 | 201621010157-Power of Attorney-070521.pdf | 2021-10-18 |
| 18 | 201621010157-Marked Copy-070521.pdf | 2021-10-18 |
| 19 | 201621010157-Form 2(Title Page)-070521.pdf | 2021-10-18 |
| 20 | 201621010157-FER.pdf | 2021-10-18 |
| 21 | 201621010157-Examination Report Reply Recieved-070521.pdf | 2021-10-18 |
| 22 | 201621010157-Claims-070521.pdf | 2021-10-18 |
| 23 | 201621010157-Amended Pages Of Specification-070521.pdf | 2021-10-18 |
| 24 | 201621010157-Abstract-070521.pdf | 2021-10-18 |
| 1 | SearchStrategyof201621010157E_11-11-2020.pdf |